Advancing an Operational Definition of Intellectual and Developmental Disabilities for Use in Research
Background. Accurately estimating the prevalence of intellectual and developmental disabilities (ID/DD) in the United States remains a challenge, with reported rates varying widely (3%-17%) based on the definitions and data sources used. Administrative data, especially from Medicare and Medicaid claims, due to their broad population coverage and longitudinal structure, can be a valuable resource for identifying and monitoring the health of individuals with many conditions, including ID/DD. However, current tools like the Centers for Medicare & Medicaid Services’ Chronic Conditions Data Warehouse (CCW) condition flags for intellectual disabilities, autism spectrum disorders, and other developmental disabilities exclude many potentially relevant diagnoses, leading to substantial variation across federal and nonfederal research in International Classification of Diseases (ICD) diagnosis codes included in claims-based ID/DD definitions.
Objectives. In this brief, we present findings from a descriptive analysis of Medicare and Medicaid administrative data and discussions with a multidisciplinary technical expert panel (TEP) toward informing a future update to the CCW condition flags for ID/DD.
Other Articles in this Edition
Approaching Adult ADHD Diagnosis and Management
Antidepressant use in pregnancy shows no clear autism or ADHD link
More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
New study reveals best dosage for ADHD medications
New Research: Undiagnosed ADHD Linked to High-Risk Driving in Adults After Traffic Accidents
Why ADHD May Not Always Look the Way Clinicians Expect
After the COVID‑19 pandemic, thousands more kindergarteners faced developmental challenges
Which Time Management Strategies Work Best for You?
Sleep Disturbance Linked to Cognitive Disengagement Syndrome in Adolescents
Psychology professor calls for more thorough diagnostic assessments for ADHD
Health Rounds: Common ADHD medicines help treat cancer-related fatigue
